CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade Merck KGaA - EUR - MRKd CFD

185.35
0.19%
0.65
Low: 184.35
High: 186.45
Market Trading Hours* (UTC) Open now
Closes on Monday at 16:30

Mon - Fri: 08:02 - 16:30

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.65
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.024161 %
Charges from borrowed part ($-0.97)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.024161%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.020283 %
Charges from borrowed part ($-0.81)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.020283%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency EUR
Margin 20%
Stock exchange Germany
Commission on trade 0%

*Information provided by Capital.com

Merck KGaA ESG Risk Ratings

High Medium Low Negligible

‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

More ESG coverage

Key Stats
Prev. Close* 185.8
Open* 184.9
1-Year Change* -3.14%
Day's Range* 184.35 - 186.45
52 wk Range 153.10-202.80
Average Volume (10 days) 291.04K
Average Volume (3 months) 6.14M
Market Cap 24.03B
P/E Ratio 23.29
Shares Outstanding 434.78M
Revenue 21.79B
EPS 7.98
Dividend (Yield %) 0.99516
Beta 0.57
Next Earnings Date Mar 2, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 3, 2023 185.80 3.60 1.98% 182.20 186.25 181.00
Feb 2, 2023 183.70 4.20 2.34% 179.50 184.80 179.45
Feb 1, 2023 181.80 -7.00 -3.71% 188.80 188.85 181.10
Jan 31, 2023 190.75 -2.60 -1.34% 193.35 193.55 189.65
Jan 30, 2023 193.60 4.10 2.16% 189.50 194.05 188.95
Jan 27, 2023 190.05 -1.40 -0.73% 191.45 191.90 189.55
Jan 26, 2023 192.30 -1.90 -0.98% 194.20 195.45 192.30
Jan 25, 2023 190.45 1.65 0.87% 188.80 191.00 187.15
Jan 24, 2023 189.45 -2.55 -1.33% 192.00 192.75 188.80
Jan 23, 2023 192.55 3.30 1.74% 189.25 193.05 188.45
Jan 20, 2023 186.55 -1.80 -0.96% 188.35 191.20 186.50
Jan 19, 2023 189.35 -1.50 -0.79% 190.85 191.00 186.80
Jan 18, 2023 192.35 -3.95 -2.01% 196.30 196.40 192.15
Jan 17, 2023 196.00 -2.70 -1.36% 198.70 198.75 195.40
Jan 16, 2023 199.20 1.15 0.58% 198.05 200.00 197.85
Jan 13, 2023 197.65 2.45 1.26% 195.20 197.75 193.15
Jan 12, 2023 196.75 -3.15 -1.58% 199.90 200.30 192.85
Jan 11, 2023 200.70 6.95 3.59% 193.75 202.20 193.55
Jan 10, 2023 192.00 2.40 1.27% 189.60 192.60 189.00
Jan 9, 2023 193.55 5.00 2.65% 188.55 193.60 187.40

Merck KGaA - EUR Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 15024 14517 14836 16152 17534 19687
Revenue 15024 14517 14836 16152 17534 19687
Cost of Revenue, Total 5201 5071 5342 5951 6782 7325
Gross Profit 9823 9446 9494 10201 10752 12362
Total Operating Expense 12543 12094 13109 14032 14549 15508
Selling/General/Admin. Expenses, Total 4409 4234 4256 4686 4600 4855
Research & Development 1972 2102 2220 2239 2262 2400
Depreciation / Amortization 1036 1020 979 923 636 589
Interest Expense (Income) - Net Operating 57 3 62 1
Unusual Expense (Income) -46 -26 339 389 85 184
Other Operating Expenses, Total -86 -310 -89 -156 184 154
Operating Income 2481 2423 1727 2120 2985 4179
Interest Income (Expense), Net Non-Operating -274 -243 -209 -338 -350 -255
Other, Net -53 -51 -57 -47 -5 0
Net Income Before Taxes 2154 2129 1461 1735 2630 3924
Net Income After Taxes 1633 2557 1093 1295 1993 3065
Minority Interest -4 -10 -22 -3 -7 -10
Net Income Before Extra. Items 1629 2547 1071 1292 1986 3055
Total Extraordinary Items 0 57 2303 28 0
Net Income 1629 2604 3374 1320 1986 3055
Income Available to Common Excl. Extra. Items 1629 2548 1071 1292 1987 3055
Income Available to Common Incl. Extra. Items 1629 2605 3374 1320 1987 3055
Diluted Net Income 1629 2605 3374 1320 1987 3055
Diluted Weighted Average Shares 434.778 434.778 434.794 434.211 434.792 434.566
Diluted EPS Excluding Extraordinary Items 3.74674 5.86046 2.46324 2.97552 4.57 7.03
Dividends per Share - Common Stock Primary Issue 1.2 1.25 1.25 1.3 1.4 1.85
Diluted Normalized EPS 3.66653 5.91727 3.04653 3.6442 4.71815 7.36072
Total Adjustments to Net Income 1 0 1
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 4631 4870 4973 5213 5198
Revenue 4631 4870 4973 5213 5198
Cost of Revenue, Total 1721 1813 1859 1959 1987
Gross Profit 2910 3057 3114 3254 3211
Total Operating Expense 3588 3821 3926 4174 4025
Selling/General/Admin. Expenses, Total 1280 1342 1376 1546 1374
Research & Development 574 585 660 590 586
Unusual Expense (Income) 6 0 -1 -6 5
Other Operating Expenses, Total 7 81 32 85 73
Operating Income 1043 1049 1047 1039 1173
Interest Income (Expense), Net Non-Operating -60 -95 -54 -47 -34
Other, Net 1 1
Net Income Before Taxes 984 955 993 992 1139
Net Income After Taxes 748 747 764 806 884
Minority Interest -1 -2 -3 -4 -3
Net Income Before Extra. Items 747 745 761 802 881
Net Income 747 745 761 802 881
Income Available to Common Excl. Extra. Items 747 745 761 802 880
Income Available to Common Incl. Extra. Items 747 745 761 802 880
Diluted Net Income 747 745 761 802 880
Diluted Weighted Average Shares 434.302 434.778 434.857 433.438 435.644
Diluted EPS Excluding Extraordinary Items 1.72 1.71352 1.75 1.85032 2.02
Dividends per Share - Common Stock Primary Issue 0 0 0 1.85 0
Diluted Normalized EPS 1.80927 1.90422 1.8827 1.80908 2.07345
Total Adjustments to Net Income 0 -1
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 7670 7455 9236 9003 9280 10982
Cash and Short Term Investments 981 623 2199 598 1234 1685
Cash & Equivalents 662 481 779 541 1109 1511
Short Term Investments 319 142 1420 57 125 174
Total Receivables, Net 3607 3707 3738 4233 3910 4345
Accounts Receivable - Trade, Net 2888 2923 3278 3644 3390 3853
Total Inventory 2609 2632 2764 3342 3294 3900
Prepaid Expenses 276 338 435 493 519 570
Other Current Assets, Total 197 155 100 337 323 482
Total Assets 38258 35621 36888 43811 41796 45362
Property/Plant/Equipment, Total - Net 4231 4512 4811 6213 6421 7217
Property/Plant/Equipment, Total - Gross 9404 9853 10551 12561 13228 14810
Accumulated Depreciation, Total -5172 -5340 -5740 -6348 -6808 -7593
Goodwill, Net 15015 13582 13764 17141 15959 17004
Intangibles, Net 9980 8317 7237 9175 7653 7612
Long Term Investments 191 419 1 3
Note Receivable - Long Term 15 41 614 746 830 922
Other Long Term Assets, Total 1156 1295 1226 1533 1652 1622
Total Current Liabilities 9089 8635 8517 11842 9231 10432
Accounts Payable 2048 2195 1766 2054 1768 2380
Accrued Expenses 603 778 799 791 975 1204
Notes Payable/Short Term Debt 1855 1173 982 2224 515 1434
Current Port. of LT Debt/Capital Leases 1908 1590 1217 2307 1780 1062
Other Current Liabilities, Total 2675 2899 3753 4466 4193 4352
Total Liabilities 24269 21618 19688 25945 24850 24024
Total Long Term Debt 8706 7947 6608 8588 9745 8270
Long Term Debt 8706 7947 6608 8130 9418 7928
Deferred Income Tax 2724 1489 1288 1828 1441 1411
Minority Interest 61 63 33 48 71 78
Other Liabilities, Total 3689 3484 3242 3639 4362 3833
Total Equity 13989 14003 17200 17866 16946 21338
Preferred Stock - Non Redeemable, Net 397 397 397 397 397 397
Common Stock 168 168 168 168 168 168
Additional Paid-In Capital 3814 3814 3814 3814 3814 3814
Retained Earnings (Accumulated Deficit) 8049 9902 12532 13236 14556 16673
Other Equity, Total 1561 -278 289 251 -1989 286
Total Liabilities & Shareholders’ Equity 38258 35621 36888 43811 41796 45362
Total Common Shares Outstanding 434.778 434.778 434.778 434.778 434.778 434.778
Capital Lease Obligations 458 327 342
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 10617 10182 10315 10982 11085
Cash and Short Term Investments 2298 1870 1665 2073 1445
Cash & Equivalents 2238 1825 1523 1899 1339
Short Term Investments 60 45 142 174 106
Total Receivables, Net 4226 4124 4207 4345 4705
Accounts Receivable - Trade, Net 3816 3771 3930 3853 4345
Total Inventory 3462 3564 3760 3900 4143
Other Current Assets, Total 631 624 683 664 792
Total Assets 43891 43145 43836 45362 46235
Property/Plant/Equipment, Total - Net 6552 6601 6761 7217 7303
Goodwill, Net 16541 16347 16670 17004 17761
Intangibles, Net 7765 7613 7628 7612 7549
Long Term Investments 770 744 794 914 905
Note Receivable - Long Term 38 39 39 35 35
Other Long Term Assets, Total 1608 1619 1629 1598 1597
Total Current Liabilities 10652 9820 9793 10432 10207
Accounts Payable 1937 2107 2132 2380 2356
Accrued Expenses 118 144 191 224 174
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 3347 3278 2770 2531 2345
Other Current Liabilities, Total 5250 4291 4700 5297 5332
Total Liabilities 24975 23852 23229 24024 23316
Total Long Term Debt 9001 8721 8195 8270 8286
Long Term Debt 9001 8721 8195 8270 8286
Deferred Income Tax 1440 1401 1374 1411 1389
Minority Interest 67 68 72 78 71
Other Liabilities, Total 3815 3842 3795 3833 3363
Total Equity 18916 19293 20607 21338 22919
Preferred Stock - Non Redeemable, Net 397 397 397 397
Common Stock 168 168 168 168 565
Additional Paid-In Capital 3814 3814 3814 3814 3814
Retained Earnings (Accumulated Deficit) 15240 15799 16556 16673 18540
Other Equity, Total -703 -885 -328 286
Total Liabilities & Shareholders’ Equity 43891 43145 43836 45362 46235
Total Common Shares Outstanding 434.778 434.778 434.778 434.778 434.778
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line 1633 2615 3396 1324 1994 3065
Cash From Operating Activities 2510 2696 2219 2856 3477 4616
Cash From Operating Activities 1934 1758 1812 1944 1938 1762
Non-Cash Items -488 -250 -2523 149 -59 62
Changes in Working Capital -569 -1427 -466 -561 -396 -273
Cash From Investing Activities -503 -1147 2191 -6153 -1340 -1578
Capital Expenditures -848 -1311 -1016 -1021 -1563 -1421
Other Investing Cash Flow Items, Total 345 164 3207 -5132 223 -157
Cash From Financing Activities -1908 -1870 -2825 1902 -1522 -2504
Financing Cash Flow Items -464 -469 -607 -527 -519 -576
Total Cash Dividends Paid -136 -155 -162 -162 -168 -181
Issuance (Retirement) of Debt, Net -1308 -1246 -2056 2591 -835 -1747
Foreign Exchange Effects 8 -30 -5 5 -40 9
Net Change in Cash 107 -351 1580 -1390 575 543
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line 748 1495 2258 3065 884
Cash From Operating Activities 1216 2104 3571 4616 840
Cash From Operating Activities 424 843 1287 1762 430
Non-Cash Items 6 25 46 62 -24
Changes in Working Capital 38 -259 -20 -273 -450
Cash From Investing Activities -346 -587 -1226 -1578 -1089
Capital Expenditures -362 -638 -1155 -1421 -498
Other Investing Cash Flow Items, Total 16 51 -71 -157 -591
Cash From Financing Activities 6 -1054 -2184 -2504 -315
Financing Cash Flow Items -55 -575 -575 -576 -100
Total Cash Dividends Paid 0 -181 -181 -181 0
Issuance (Retirement) of Debt, Net 61 -298 -1428 -1747 -215
Foreign Exchange Effects 7 6 7 9 4
Net Change in Cash 883 469 168 543 -560
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
BlackRock Institutional Trust Company, N.A. Investment Advisor 6.8422 8842949 0 2022-09-27 LOW
MFS Investment Management Investment Advisor/Hedge Fund 4.84 6255325 3997581 2022-09-27 LOW
Fidelity International Investment Advisor 3.0193 3902150 2587266 2022-09-19 LOW
Fidelity Management & Research Company LLC Investment Advisor 2.9271 3783100 -924069 2022-05-18 LOW
Amundi Asset Management, SAS Investment Advisor/Hedge Fund 2.8682 3706864 -407104 2022-12-14 HIGH
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.8079 3629024 3672 2022-12-31 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 2.3464 3032598 488031 2022-12-31 LOW
DWS Investment GmbH Investment Advisor/Hedge Fund 1.9124 2471640 83238 2022-12-31 LOW
FMR Investment Management (U.K.) Limited Investment Advisor 1.3005 1680776 -5936 2022-12-31 LOW
Deka Investment GmbH Investment Advisor/Hedge Fund 1.1334 1464775 -25955 2022-12-31 LOW
BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 1.1038 1426513 15622 2022-12-31 LOW
Allianz Global Investors GmbH Investment Advisor 1.0531 1361000 -28942 2022-11-30 LOW
Union Investment Privatfonds GmbH Investment Advisor 0.9614 1242564 560959 2022-09-30 LOW
Eleva Capital SAS Investment Advisor 0.8919 1152665 25800 2022-10-31 HIGH
MFS International Singapore Pte. Ltd Investment Advisor 0.8661 1119411 -22611 2022-12-31 LOW
BNP Paribas Asset Management France SAS Investment Advisor/Hedge Fund 0.8255 1066840 -1655 2022-12-31 LOW
Lazard Asset Management, L.L.C. Investment Advisor/Hedge Fund 0.7985 1031971 -21628 2022-12-31 LOW
Walter Scott & Partners Ltd. Investment Advisor/Hedge Fund 0.7721 997924 -204 2022-12-31 LOW
J O Hambro Capital Management Limited Investment Advisor/Hedge Fund 0.7686 993311 -119431 2022-09-30 MED
California Public Employees' Retirement System Pension Fund 0.7543 974843 -146711 2021-06-30 LOW

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
+485000+

Traders

65000+

Active clients monthly

$48000000+

Monthly investing volume

$28000000+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Merck - EUR Company profile

About Merck KGaA

Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Electronics business enables digital living and provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Merck KGaA revenues increased 12% to EUR19.69B. Net income applicable to common stockholders increased 54% to EUR3.06B. Revenues reflect Life Science segment increase of 20% to EUR8.99B, Healthcare segment increase of 7% to EUR7.09B, United States (Country) segment increase of 13% to EUR5.25B, Rest of Europe segment increase of 14% to EUR4.03B.

Equity composition

2003 Q1 has been restated to reflect discontinued operations. 01/2007, Rights Issue, 4 new shares for every 29 shares held @ EUR 78 (Factor: 1.015602). 6/2014, 2-for-1 stock split (Factor: 2).

Industry: Proprietary & Advanced Pharmaceuticals

Frankfurter Str. 250
DARMSTADT
HESSEN 64293
DE

Income Statement

  • Annual
  • Quarterly

People also watch

XRP/USD

0.40 Price
+0.040% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 0.00366

Natural Gas

2.42 Price
+0.290% 1D Chg, %
Long position overnight fee -0.1117%
Short position overnight fee 0.0782%
Overnight fee time 22:00 (UTC)
Spread 0.005

US100

12,509.60 Price
-0.540% 1D Chg, %
Long position overnight fee -0.0184%
Short position overnight fee 0.0072%
Overnight fee time 22:00 (UTC)
Spread 1.8

Oil - Crude

74.01 Price
+0.710% 1D Chg, %
Long position overnight fee -0.0222%
Short position overnight fee 0.0064%
Overnight fee time 22:00 (UTC)
Spread 0.03

Still looking for a broker you can trust?

Join the 480.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading